Question 1

How many shares of CTXR does GEODE CAPITAL MANAGEMENT, LLC own?

Accepted Answer

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC holds 215,537 shares of CTXR (CITIUS PHARMACEUTICALS INC).

Question 2

What is GEODE CAPITAL MANAGEMENT, LLC's CTXR position worth?

Accepted Answer

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC's CTXR position is worth $130,302.

Question 3

Is GEODE CAPITAL MANAGEMENT, LLC buying or selling CTXR?

Accepted Answer

In 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC decreased their CTXR position (-12.4% change in shares).

Question 4

When did GEODE CAPITAL MANAGEMENT, LLC first buy CTXR?

Accepted Answer

Based on available 13F filings, GEODE CAPITAL MANAGEMENT, LLC first reported a position in CTXR in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	215,537	-12.4%	$130,302	0.0%	$0.61	0
2026-Q1	Increased	246,158	+93.0%	$221,556	0.0%	$0.74	25
2025-Q4	Increased	127,533	+6.5%	$99,104	0.0%	$0.78	16
2025-Q3	Increased	119,771	+57.4%	$148,536	0.0%	$1.18	22
2025-Q2	Decreased	76,095	-14.8%	$121,015	0.0%	$1.53	0
2025-Q1	Increased	89,275	+16.7%	$133,047	0.0%	$1.55	18
2024-Q4	New	76,506	-	$306,097	0.0%	$3.91	36

CTXR7 quarters

CTXR
7 quarters